People: Exelixis Inc (EXEL.O)
4.61USD
3:14pm EDT
$0.12 (+2.56%)
$4.55
$4.50
$4.63
$4.50
643,052
1,413,425
$6.95
$4.19
Morrissey, Michael
Brief Biography
Dr. Michael M. Morrissey, Ph.D., serves as President, Chief Executive Officer, Director of Exelixis, Inc., since July 15, 2010. Dr. Morrissey has held positions of increasing responsibility at Exelixis since he joined the company in February 2000, including serving as President of Research and Development from January 2007 until July 2010. From 1991 to 2000, Dr. Morrissey held several positions at Berlex Biosciences, last holding the position of Vice President, Discovery Research. He is the author of numerous scientific publications in medicinal chemistry and drug discovery and an inventor on 70 issued U.S. patents and 25 additional published U.S. patent applications. Dr. Morrissey holds a B.S. (Honors) in Chemistry from the University of Wisconsin and a Ph.D. in Chemistry from Harvard University.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 1,056,970 | -- | 2,287,910 | 3,344,880 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | 330,000 | 755,450.00 |
| Unexercisable | 375,000 | 193,500.00 |
| Excercised | 82,500 | -- |
| Name | Fiscal Year Total |
|---|---|
Stelios Papadopoulos |
-- |
Michael Morrissey |
3,344,880 |
Frank Karbe |
1,368,970 |
Peter Lamb |
-- |
Pamela Simonton |
1,310,610 |
J. Scott Garland |
1,273,040 |

